Skip to main content
Terug
WHTCF logo

WELL Health Technologies Corp.

Datakwaliteit: 100%
WHTCF
OTC Healthcare Medical - Care Facilities
€ 2,69
▼ € 0,03 (-0,99%)
Marktkapitalisatie: 686,43M
Dagbereik
€ 2,69 € 2,69
52-Weeksbereik
€ 2,60 € 4,31
Volume
500
50D / 200D Gem.
€ 2,99 / € 3,20
Vorige Slotkoers
€ 2,71

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (627 peers)

Metriek Aandeel Sector Mediaan
P/E -13,7 0,3
P/B 0,8 2,9
ROE % -5,8 3,7
Net Margin % -3,6 3,8
Rev Growth 5Y % 46,7 10,0
D/E 0,8 0,2

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2028 € 0,30
€ 0,29 – € 0,31
 1,8 B 1
FY2027 € 0,39
€ 0,38 – € 0,40
 1,7 B 1
FY2026 € 0,28
€ 0,27 – € 0,29
 1,6 B 1

Belangrijkste Punten

Revenue grew 46,67% annually over 5 years — strong growth
Earnings declined -253,85% over the past year
Generating 87,85M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5,45%
Capital efficient — spends only 1,99% of revenue on capex
ROIC of 29,48% — excellent capital efficiency

Groei

Revenue Growth (5Y)
46,67%
Revenue (1Y)52,12%
Earnings (1Y)-253,85%
FCF Growth (3Y)22,72%

Kwaliteit

Return on Equity
-5,80%
ROIC29,48%
Net Margin-3,59%
Op. Margin44,20%

Veiligheid

Debt / Equity
0,82
Current Ratio1,03
Interest Coverage11,36

Waardering

P/E Ratio
-13,68
P/B Ratio0,80
EV/EBITDA2,04
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 52,12% Revenue Growth (3Y) 34,27%
Earnings Growth (1Y) -253,85% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 46,67% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,40B Net Income (TTM) -50,17M
ROE -5,80% ROA -2,39%
Gross Margin 37,50% Operating Margin 44,20%
Net Margin -3,59% Free Cash Flow (TTM) 87,85M
ROIC 29,48% FCF Growth (3Y) 22,72%
Safety
Debt / Equity 0,82 Current Ratio 1,03
Interest Coverage 11,36 Dividend Yield 0,00%
Valuation
P/E Ratio -13,68 P/B Ratio 0,80
P/S Ratio 0,49 PEG Ratio 1,09
EV/EBITDA 2,04 Dividend Yield 0,00%
Market Cap 686,43M Enterprise Value 1,26B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1,40B 919,69M 776,05M 569,14M 302,32M
Net Income -50,17M 32,61M 82.000,0 1,37M -43,79M
EPS (Diluted) -0,03 0,13 0,00 0,01 -0,23
Gross Profit 524,65M 363,01M 372,27M 303,29M 153,70M
Operating Income 618,34M -30,20M 35,16M 23,31M -12,79M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2,10B 1,81B 1,41B 1,32B 1,26B
Total Liabilities 1,06B 877,55M 563,16M 503,78M 554,37M
Shareholders' Equity 862,80M 867,61M 767,67M 732,34M 618,24M
Total Debt 710,38M 425,09M 426,28M 358,42M 401,94M
Cash & Equivalents 133,65M 131,67M 43,42M 48,91M 61,92M
Current Assets 369,30M 346,11M 176,40M 150,88M 142,91M
Current Liabilities 357,17M 382,08M 152,95M 136,50M 137,30M

Strategiescores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Growth Price/Sales Ratio Focus (Ken Fisher)
#3 of 618
97
Custom Full Throttle
#11 of 146
72

Recente Activiteit

Ingestapt Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Ingestapt Full Throttle
Mar 24, 2026